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We recently developed a novel promoter assay system using a retroviral vector (pIPZOO series). Transcription from the internal promoter, which 
had been inserted for the promoter assay, was shown to be interfered with by transcription from the upstream long terminal repeat (LTR). Here 
we report a new high-titer ‘seIf-inactivating’ vector, in which tran~~ption interference was virtually eliminated. This new vector was constructed 
by introducing only a very minor mutation into the ‘TATA box’ in the 3’-LTR. This mutation was successfully transferred to the S-LTR after 
reverse transcription, yielding a provirus incapable of transcribing viral RNA. The viral titer was not reduced by the mutation, permitting general 
application of this virus. 
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1. INTRODUCTION 
We recently developed a novel promoter assay system 
using a retroviral vector (pIPZOO series), which enabled 
us to detect promoter activity in individual brain cells 
in primary culture [1,2]. The structure of this vector with 
a nuclear location signal at the amino-terminus of the 
~-galactosidase @-gal) is illustrated in Fig. 1A (pIP211). 
Two kinds of transcripts are produced from this vector: 
one from the S-LTR and another from the inserted 
promoter. However, on the longer transcript, since the 
translational initiation codon (ATG) of the la&Z gene 
is the second ATG codon following that of the neu gene, 
translational efficiency of the B-gal from this transcript 
is greatly reduced in eukaryotic cells. On the other hand, 
on the shorter transcript, the ATG codon of la&Z is the 
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first one and initiates translation efficiently. Thus, B-gal 
is produced reflecting the cell type-specific activation of 
the inserted promoter. The effect of the enhancers in 
LTRs were not detectable in our recent studies [1,2]. 
One of the problems with this vector system is the 
possibility that the transcription itself from the internal 
promoter might be affected by the readthrough tran- 
scription from the 5’-LTR (promoter interferen~) [3-6]. 
In order to determine whether there is promoter inter- 
ference in this vector and to improve the system, we 
have constructed a new ‘self-inactivating (SIN) type’ 
retroviral vector. By using this vector with SV40 early 
promoter as an internal promoter, the extent of pro- 
moter inte~erence was measured. SV40 promoter with- 
out transcription from the upstream LTR promoter 
gives 1.4 times more transcript han that with overriding 
transcription, indicating the necessity of using SIN vec- 
tor for promoter assay. Previously reported SIN vectors 
delete the viral enhancer or both the viral enhancer and 
the promoter upon integration into the host genome 
[7-131. Most authors have reported very low titers with 
these vectors, which prevented their general application. 
Soriano et al. reported a high-titer SIN vector [13], but 
since they deleted only the enhancer and self-inactiva- 
tion is insu~cient, that type of vector is not suitable for 
our purpose. Reduced titers of SIN vectors are proba- 
bly due to destruction of the steric structure important 
for 3’ RNA processing [8]. Therefore, we have intro- 
duced a very minor mutation only in the ‘TATA box’ 
in the 3’-LTR, and succeeded in producing high-titer 
virus with sufficient ‘self-inactivation’. 
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Fig. 1. Construction of SV/pIP311. (A) The sequence of ‘TATA box’ in the 3’-LTR of SWpIP211 was mutated to the GAATTC sequence, which 
is the recognition site for EcoRI restriction enzyme. (B) pNK9172 plasmid is the same as pIF9171 plasmid [1] except hat the ‘TATA box’ in the 
3’-LTR was mutated (shown as a hatched region). SV/pIP311 plasmid was constructed from pNK9172 and SV/pIPZl 1 [15] plasmids. 
2. MATERIALS AND METHODS 
2.1. Construction of SVlpIP311 plasmid 
Site-directed in vitro mutagenesis using a heteroduplex intermediate 
was carried out in pIF9171 plasmid [l] as reported previously [14], 
which converted the ‘TATA box’ (AATAAA) in the 3’-LTR to the 
GAATTC sequence. The sequence of the oligonucleotide used in this 
process was: 5’-CCCCGAGCTCGAATTCAGAGCCCAC-Y, which 
was synthesized by a Beckman system 1E DNA synthesizer. The 
3.9-kb Mel- SpeI fragment of this mutated plasmid (pNK9172) was 
used to replace the corresponding region of SVlpIP211 plasmid [I 51 
to construct the SVlpIP311 plasmid (Fig. IB). 
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2.2. F~aores~ence-activated eel1 sorting 
Cells were harvested and resuspended at 3.5 x 106-4.2 x 10’ cellslml 
in phosphate-buffered saline (PBS) containing 10 mM HEPES and 4% 
fetal calf serum (FCS). Fluorescein-di-/&u-galactopyranoside (FDG) 
[16] was added to a final concentration of 1 mM, and the mixture was 
incubated at 37°C for 1 min. The reaction was stopped by adding 10 
~01s. of ice-cold PBS containing 10 mM HEPES, 4% FCS, and 1 fig 
of propidium iodide (PI) per ml. Fluore~in-p~itive and PI-negative 
cells were sorted and collected on a FACStar PLUS (Beckton Dickin- 
son). These cells were cultured and used for the second round of cell 
sorting to eliminate most of the @-gal negative cells. 
2.3. Northern blot analysis 
Total RNAs were extracted by the guanidinium thiocyanate method 
and separated on a 1.5% formaldehyde agarose gel. The RNAs were 
then transferred to a Zeta-Probe membrane (Bio-Rad) with 10 x SSC 
(1 x SSC: 150 mM NaCl, 15 mM sodium citrate). The l.l-kb SacI- 
EcoRI fragment of the IacZ gene and the 2.0-kb PstI fragment of a 
chicken /?-actin cDNA clone, pA1 [I 9 were 32P-labeled with a Ran- 
dom Primer Labeling Kit (Boehringer Mannheim) and used as probes. 
Membranes were washed, and exposed to a Kodak X-Omat AR film 
at -70°C or to an imaging plate of a Bio-Image Analyzer BAS2000 
(Fuji). 
2.4. Estimation of the viral titers 
Ten independent clones of G418-resistant packaging cells @2) were 
randomly selected and isolated, and the viral supematants were col- 
lected. NIH 3T3 cells were plated at 1 x IO4 cells/cmz, cultured for 24 
h, and infected with each clone of virus with 8pg of polybrene per ml. 
The cells were processed for X-Gal (5bromo-4-chloro-3-indolyl-& 
galactoside: a substrate of /I-gal) staining [I] 44 h after the viral infec- 
tion. The numbers of X-Gal-positive cells per 1 ml of the added 
supematants were calculated. 
3. RESULTS AND DISCUSSION 
In this study, we used SV/pIP211 vector as a model 
system, which has an SV40 early promoter and a nu- 
clear location signal at the amino-terminus of /?-gal 
[2,15]. The nuclear location signal restricts the localiza- 
tion of p-gal to the nucleus, which makes it very easy 
to identify each p-gal-positive cell In order to construct 
a ‘SIN’ vector without any severe destruction of the 
steric structure of 3’-LTR, we changed the sequence of 
the ‘TATA box’ (AATAAA) in the 3’-LTR to a 
GAATTC sequence without any deletion to construct 
SV/pIP311 (Fig. 1A). This mutation is expected to be 
transferred to the S-LTR after reverse transcription, 
yielding a provirus incapable of transcribing viral RNA 
(Fig. 2). Recombinant retroviruses were produced as 
described previously [I]. 
We used NIH 3T3 cells as the target cells for infec- 
tion, and the infected cells were collected by the FDG- 
FACS (fluorescence-activated cell sorter) method, be- 
cause the neo gene is not expressed from the SV/pIP3 11 
provirus and selection with G418 is impossible. Results 
of two rounds of cell sorting are shown in Fig. 3A. More 
than 95% of the collected cells were X-Gal-positive. 
Northern blot analysis of the RNA from these cells with 
a ZucZ probe revealed that the longer transcript from the 
5’-LTR of SV/pIP3 11 provirus was barely detected (Fig. 
3B), which proved efficient ‘self-inactivation’ of this 
pIP3llplasmid 
Fig. 2. Summary of production of pIP3 11 virus. A packaging cell line, 
42, was transfected with pIP311 plasmid containing an inserted pro- 
moter. In this cell, two kinds of transcripts are produced (dotted lines), 
while only the longer one is packaged to a recombinant retrovirus 
particle. This retrovirus was recovered as the culture supematant and 
was used to infect target cells. In the infected cells, only the transcript 
from the internal promoter can be produced, because the mutation of 
the ‘TATA box’ in the 3’-LTR is transferred to the S-LTR after 
reverse trancsription. 4, packaging signal; shadowed region, mutation 
in the ‘TATA box’. 
virus. In addition, qu~tifi~tion of the bands by a Per- 
sonal Densitometer PDl 10 (Molecular Dynamics) or a 
Bio-Image Analyzer BAS2000 (Fuji) showed that the 
transcript from the SV40 early promoter from pIP311 
provirus was about 1.4 times more abundant than that 
from pIP2 11 provirus. The SV/pIP3 11 virus-infected 
cells were always more densely stained by X-Gal than 
those infected by SVlpIP211 virus under the same stain- 
ing condition (Fig. 3A), which is in good agreement 
with the RNA analysis. These results clearly show that 
the transcription from the S-LTR indeed interferes with 
the transcription from the internal promoter in pIP211 
vector. 
Next we compared the titers of two recombinant 
retroviruses (pIP211, pIP3I 1) by counting the X-Gal 
positive cells, because SVlpIP311 vies-infected cells 
cannot be counted as the conventional G418-resistant 
colony-forming units. Firstly, we estimated what pro- 
portion of the SV/pIP211 -infected cells produces suffi- 
cient /?-gal to be detected by X-Gal staining, because the 
presence of promoter suppression in SVlpIPZll pro- 
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Fig. 3. RNA analysis of the cells collected by a FACS. (A) Comparison of the cells before and after two rounds of cell sorting. Portions of the 
collected cells were cultured overnight and stained with X-Gal. (B) Northern blot analysis with a luc.2 probe (upper panel). Results of rehybridization 
of the same membrane with a/I-actin probe are shown in the lower panel. The longer transcript from the S-LTR was barely detected in cells infected 
with SV/pIP311 virus (shown by the arrowhead). Lane I, control cells without infection by any virus; lane 2, cells infected with SV/pIPZI 1 virus; 
lane 3, cells infected with SVlpIP311 virus. 
virus has now been proven. NIH 3T3 cells were infected 
with SV/pIP211 virus, cultured and selected with 1.5 
2.0 mg of G418 per ml for 12 days, and processed for 
X-Gal staining as described previously [l]. Some of the 
infected cells were cultured for 9 days without G418 
after selection for 9 days. Both of these cell cultures 
showed 95.0-95.3% X-Gal-positive cells, indicating that 
the titer of SV/pIPPll virus can be roughly estimated 
by counting the X-Gal-positive cells. Titers of 10 ran- 
domly selected clones of 42 cells harboring SV/pIP211 
and SV/pIP3 11 were determined as described in section 
2 (Table I). Both the maximum and the average titers 
were higher in SV/pIP311 vies-producing cells than in 
SWpIP211 virus-producing cells. At least the mutation 
introduced into the SV/pIP311 virus did not reduce its 
titer, although the titers of most of the previously re- 
ported SIN vectors were severely reduced. This is prob- 
ably because only a minor mutation had been intro- 
duced and it did not affect the steric st~cture of the 
3’-LTR severely, permitting efficient processing of the 
3’-end of the RNA. 
In conclusion, we have constructed a new high-titer 
‘self-inactivating type’ pIP3 11 vector. RNA analysis re- 
vealed the presence of promoter interference in pIP21 I 
vector, showing that pIP311 vector is more suitable for 
semi-quantitative promoter assay. 
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Table I 
Viral titers of SVfpIP211 and SV/piP311 
SVlpIP2 11 SVlpIP3 1 I
Clone Number of X-Gal Clone Number of X-Gal 
no. positive cells no. positive cells 
(x lo3 cellslml) {x IO3 cells/ml) 
1 53.8 1 108.8 
2 10.0 2 32.8 
3 4.1 3 22.7 
4 2.9 4 16.7 
5 24.6 5 0.9 
6 4.3 6 3.8 
7 3.1 7 17.9 
8 0.6 8 43.6 
9 6.9 Q 190.0 
10 0.3 IO 0.6 
Ave. 11.1 Ave. 43.8 
Viral titers were estimated by counting X-Gal positive cells 44 h after 
the viral infection. Randomly selected ten independent clones of 42 
cells harboring SV/pIP2 11 and SV/pIP3 11 were examined, 
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